CORMEDIX INC (CRMD) — insider trading
Health Care · NASDAQ
CORMEDIX INC (CRMD) has 16 reported SEC Form 4 insider transactions in our data (latest 2026-02-04).
Recent Form 4 transactions
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-02-04 | Todisco Joseph | Director, Officer (Chief Executive Officer) | Grant / award / vesting | 77,156 | $0.00 | $0 | Form 4 |
| 2026-02-04 | Hurlburt Elizabeth | Officer (Chief Operating Officer) | Grant / award / vesting | 36,006 | $0.00 | $0 | Form 4 |
| 2026-02-04 | Zelnick Kaufman Beth | Officer (Chief Legal Officer) | Grant / award / vesting | 36,006 | $0.00 | $0 | Form 4 |
| 2026-01-26 | Stewart Robert A | Director | Grant / award / vesting | 30,453 | $0.00 | $0 | Form 4 |
| 2026-01-26 | DUNTON ALAN W | Director | Grant / award / vesting | 30,453 | $0.00 | $0 | Form 4 |
| 2026-01-26 | Lefkowitz Steven W | Director | Grant / award / vesting | 30,453 | $0.00 | $0 | Form 4 |
| 2026-01-26 | Dillione Janet | Director | Grant / award / vesting | 30,453 | $0.00 | $0 | Form 4 |
| 2026-01-26 | Kaplan Myron | Director | Grant / award / vesting | 30,453 | $0.00 | $0 | Form 4 |
| 2026-01-23 | Todisco Joseph | Director, Officer (Chief Executive Officer) | Shares withheld for taxes / exercise cost | 27,306 | $7.27 | $198.5K | Form 4 |
| 2026-01-23 | Todisco Joseph | Director, Officer (Chief Executive Officer) | Grant / award / vesting | 225,900 | $0.00 | $0 | Form 4 |
| 2026-01-23 | Hurlburt Elizabeth | Officer (Chief Operating Officer) | Shares withheld for taxes / exercise cost | 10,778 | $7.27 | $78.4K | Form 4 |
| 2026-01-23 | Hurlburt Elizabeth | Officer (Chief Operating Officer) | Grant / award / vesting | 93,010 | $0.00 | $0 | Form 4 |
| 2026-01-23 | Zelnick Kaufman Beth | Officer (Chief Legal Officer) | Shares withheld for taxes / exercise cost | 8,803 | $7.27 | $64.0K | Form 4 |
| 2026-01-23 | Zelnick Kaufman Beth | Officer (Chief Legal Officer) | Grant / award / vesting | 72,820 | $0.00 | $0 | Form 4 |
| 2026-01-23 | Blum Susan | Officer (Chief Financial Officer) | Shares withheld for taxes / exercise cost | 9,767 | $7.27 | $71.0K | Form 4 |
| 2026-01-23 | Blum Susan | Officer (Chief Financial Officer) | Grant / award / vesting | 72,820 | $0.00 | $0 | Form 4 |
Ask the chat about CRMD's insider activity →
Transaction types are the SEC Form 4 codes: open-market purchases (P) and sales (S) are the only rows that reflect open-market conviction. Awards/vesting (A), option exercises (M/X/C), shares withheld for taxes (F) and gifts (G) are compensation or mechanical, not buying or selling on the open market. Sales may be planned and non-discretionary (e.g. a Rule 10b5-1 plan); open-market buying is not a recommendation to buy. Informational only — not financial advice.
Source: SEC EDGAR Form 3/4/5. See the full company profile: CORMEDIX INC (CRMD).
Last updated 2026-02-04 (most recent filing date).
Informational only — NOT financial advice. Insider filings are sourced from SEC EDGAR and shown with their reported dates.